Embolx led the effort to secure the new code for OBL procedures using the Sniper Balloon Occlusion Microcatheter, working in close collaboration with CMS over more than a year. Embolx is proud to have driven the initiative that created this new reimbursement pathway, which the company believes will improve patient access to pressure-generating catheter procedures in a lower-cost care setting.

“We are grateful to CMS for their collaboration throughout this process, and to our physician advisors, reimbursement consultants, attorneys and staff who guided us every step of the way,” said Michael Allen, CEO of Embolx. “This new code expands access to pressure-generating catheters to a lower-cost site of service where patients receive high-quality care.”